About the Anal Cancer Session
Anal cancer is a relatively rare type of cancer that forms in the tissues of the anus. While it's not as common as other types of cancer, such as colorectal cancer, its incidence has been rising steadily in recent years. Research into anal cancer focuses on understanding its causes, which often include infection with human papillomavirus (HPV), as well as identifying effective treatment options. Studies explore various approaches, including surgery, chemotherapy, and radiation therapy, either alone or in combination. Additionally, there's ongoing research into immunotherapy and targeted therapy to improve outcomes for patients with advanced or recurrent anal cancer. Early detection through screening and education about risk factors remain crucial in the fight against this disease.
Topics Covered in Anal Cancer
Squamous Cell Carcinoma
HPV-Related Disease
Precancerous Lesions
High-Risk Screening
Chemoradiation
Salvage Surgery
Related Scientific Sessions at CIOC 2027
Why Attend the Anal Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Anal Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Anal Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Anal Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Anal Cancer Conference 2027 — FAQs
What is the Anal Cancer track at CIOC 2027?
The Anal Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Anal Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Anal Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Anal Cancer are all welcome — whether presenting or attending.
Can I present my research in the Anal Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Anal Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Anal Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.